
-
Katy Perry set to roar into space on all-female flight
-
Xi warns protectionism 'leads nowhere' as he arrives in Vietnam
-
Trump hosts El Salvador's Bukele, key ally in anti-migrant push
-
Trump spotlight divides S.Africa's Afrikaners
-
South Korea's ex-president denies insurrection at criminal trial
-
World leaders slam deadly Russian strike on Ukraine
-
Chinese exports soared in March ahead of Trump's 'Liberation Day'
-
'We can get it' - Emery eyes Champions League comeback against PSG
-
Perfect Piastri puts McLaren in driving seat
-
Flick has Barcelona on cusp of return to European elite
-
Noboa wins Ecuador presidential runoff, rival claims fraud
-
China's exports beat forecast in March despite trade war woes
-
Solar park boom threatens Spain's centuries-old olive trees
-
Trump tariff rollercoaster complicates ECB rate call
-
Asian stocks rise on electronics tariffs exemption, gold hits new high
-
South Korea's ex-president attends first day of criminal trial
-
Nobel Literature Prize winner Mario Vargas Llosa dies in Peru
-
A coffin for Pol Pot's memory, 50 years after Phnom Penh's fall
-
McIlroy in no mood to talk on the way to Masters win: DeChambeau
-
Vargas Llosa, last of Latin America's literary golden generation
-
Incumbent Noboa wins Ecuador presidential runoff
-
Rollercoaster carries McIlroy to Masters glory at last
-
German archive where victims of the Nazis come back to life
-
From deadly rave to recovery: Israeli study examines MDMA's effect on trauma
-
McIlroy rides luck of the Irish to overcome Masters
-
Xi warns protectionism 'leads nowhere' as starts SE Asia tour
-
Brazil ex-president Bolsonaro surgery ends 'with success'
-
Ten birdies not enough as Rose falls to McIlroy in Masters playoff
-
Post Malone and Megan Thee Stallion primed to close out Coachella
-
Zelensky urges Trump to visit Ukraine to see war devastation: CBS
-
Trump warns no country 'off the hook' on tariffs
-
Incumbent Noboa leads Ecuador presidential runoff
-
McIlroy completes career Grand Slam with emotional Masters playoff win
-
Harden bags 39 as Clippers edge Warriors to clinch play-off spot
-
Trump downplays tariffs walk-back, says no country 'off the hook'
-
Polls close in Ecuador's razor-tight presidential runoff
-
USA, Japan win to qualify for BJK Cup finals
-
Russian missile strike on Ukraine city kills 34
-
Lyon close in on Champions League, Saint-Etienne snatch draw
-
McIlroy leads by four as Masters back-nine battle begins
-
Lazio and Roma share derby spoils as Atalanta relaunch Champions League bid
-
Children's show 'Yo Gabba Gabba!' takes Coachella by storm
-
Fabio Grosso's Sassuolo return to Serie A after a year away
-
Red Bull reflect on 'bad' Bahrain weekend
-
WHO says child killed after Israel strike hits Gaza hospital
-
Trump advisor Navarro looks to cool spat with Musk
-
Moviegoers digging 'Minecraft Movie,' tops in N.America theaters
-
Paris Olympic torches, other memorabilia auctioned off
-
Ecuador votes in razor-tight presidential runoff
-
Kohli, Karn star as Bengaluru and Mumbai win in IPL

US greenlights pig kidney transplant trials
Two US biotech companies say the Food and Drug Administration has cleared them to conduct clinical trials of their gene-edited pig kidneys for human transplants.
United Therapeutics along with another company, eGenesis, have been working since 2021 on experiments implanting pig kidneys into humans: initially brain-dead patients and more recently living recipients.
Advocates hope the approach will help address the severe organ shortage. More than 100,000 people in the United States are awaiting transplants, including over 90,000 in need of kidneys.
United Therapeutics's approval, announced Monday, allows the company to advance its technology toward a licensed product if the trial succeeds.
The study authorization was hailed as a "significant step forward in our relentless mission to expand the availability of transplantable organs," by Leigh Peterson, the company's executive vice president.
The trial will initially enroll six patients with end-stage renal disease before expanding to as many as 50, United Therapeutics said in a statement. The first transplant is expected in mid-2025.
Meanwhile, rival eGenesis said it had received FDA approval in December for a separate three-patient kidney study.
"The study will evaluate patients with kidney failure who are listed for a transplant but who face a low probability of receiving a deceased donor offer within a five-year timeframe," the company said.
Xenotransplantation -- transplanting organs from one species to another -- has been a tantalizing yet elusive goal for science.
Early experiments in primates faltered, but advances in gene editing and immune system management have brought the field closer to reality.
Pigs have emerged as ideal donors: they grow quickly, produce large litters, and are already part of the human food supply.
United Therapeutics said trial patients would be monitored for life, assessing survival rates, kidney function, and the risk of zoonotic infections -- diseases that jump from animals to humans.
Currently, there is only one living human recipient of a pig organ: Towana Looney, a 53-year-old from Alabama who received a United Therapeutics kidney on November 25, 2024.
She is also the longest-surviving recipient, having lived with a pig kidney for 71 days as of Tuesday. David Bennett of Maryland received a pig heart in 2022 and survived 60 days.
W.Morales--AT